Membranoproliferative glomerulonephritis (type II); Glomerulonephritis - membranoproliferative (type II); Mesangiocapillary glomerulonephritis (type II); Dense deposit disease; MPGN II
Treatment varies according to the symptoms. The goals of treatment are to reduce symptoms, prevent complications, and slow the worsening of the disorder.
Dietary adjustments may include restrictions on sodium, fluids, protein, or other restrictions to control high blood pressure, swelling, and accumulation of waste products in the bloodstream.
Medicines used to treat this condition and symptoms may include:
Dialysis or kidney transplantation may eventually be needed to manage renal failure.
The disorder progresses slowly to chronic renal failure. Fifty percent of cases will develop chronic renal failure within 10 years.
Call for an appointment with your health care provider if symptoms indicate MPGN II.
Call for an appointment with your health care provider if symptoms worsen or new symptoms develop, including decreased urine output.